DOCSLIB.ORG

Government of West Bengal Phone No (033) 2265 4417/4418/4419 Memono...HSIT|Ar-T3-ZOLS/6T5S~` Category of Category Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Government of West Bengal Phone No (033) 2265 4417/4418/4419 Memono...HSIT|Ar-T3-ZOLS/6T5S~` Category of Category Of Government of West Bengal Office of the Deputy Director of Health Services (E&S) Central Medical Stores, 141, A J C Bose Road, Kolkata -700 014 Phone No (033) 2265 4417/4418/4419 E mail : [email protected] MemoNo...HSIT|ar-T3-ZOLS/6T5S~` Dated: 21.06.2018 CORRIGENDUM NOTICE IN RESPECT OF e-TENDER FOR PROCUREMENT OF KITS, CHEMICALS & REAGENTS FOR SUPPLY TO THE HEALTH UNITS UNDER THE STATE OF WEST BENGAL FOR THE YEAR 2018-20 VIDE NIT NO. HST/4T-23- 2018/CR/2018-20/058, Dated 13.06.2018 SlNO. Subject Existing Proposed to be revised "Annual Turnover 1. For Manufacturer(s)/Direct Importer(s), For Manufacturer(s)/Direct Importer(s), requirement" in ......would only be eligible to participate ...... would only be eligible to participate clause no. 8 of the .termsand in the Tender. in the Tender. Category of Minimum Category of Minimum conditions of the Bidders Av. Annual Bidders Av. Annual tenderi Turnover forthelast3FY-NetofTaxes Turnover forthelast3FY-NetofTaxes (a) Bidders intending Rs. 5 Crore (a) Biddersintending Rs. 3 Crore to supply up to 5 to supply up to 10 (five) items (Ten) items (b) Bidders intending Rs.12.5 (b) Bidders intending Rs. 5 Crore to supply more Crore to supply more than 5(five) and than 10 (Ten) and up tol0 (ten) up to 20 (Twenty) items items (c) Bidders intending Rs. 25 Crore (c) Bidders intending Rs.12.5 to supply more to supply more crore I than 10(ten) and than 20 (Twenty) up to 20 (twenty) and up to 50 items (Fifty) items (d) Bidders intending Rs. 125 Crore (d) Bidders intending Rs. 25 Crore to supply more to supply more than 20 (twenty) than 50 (Fifty) items items For MSMEs, registered in West Bengal For MSMEs, registered in West Bengal whose average annual Turn Over Net of whose average annual Turn Over Net of Taxes for last 3 (three) financial years... is Taxes for last 3(three) financial years... is at least Rs.1 (One) Crore would also be at least Rs. 50 (Fifty) Lakh would also be eligib e to participate in the Tender for eligib e to participate in the Tender for SuPP y of up to 5(five) items. If they SuPP y of up to 5(five) items. If they intend to participate for supply of more intend to participate for supply of more than 5 items, the additional Turn Over than 5 items, the additional Turn Over (Net of Taxes) requirement would be (Net of Taxes) requirement would be calculated @ Rs. 20 Lakh per item calculated @ Rs.10 Lakh per item ``Annual Turnover 2. lf Out-of-state Bidder proposes that order lf Out-of-state Bidder proposes that order requirement for a and payment are to be made in the and payment are to be made in the ...... Distributor" in ......authorized Distributors with authorized Distributors with minimum clause no.11. (c) of minimum annual turnover of Rs. 2 (Two ) annu al turnover of Rs.1 (One ) crore for the terms andconditionsofthetender crore for the year 2015-16 or 2016-17. the year 2015-16 or 2016-17. ``Order & Supply" in 3. All supplies will have to be completed by All supplies will have to be completed by clause no.17. (111) door delivery within stipu ated time door delivery within stipu ated time of the terms and period mentioned below : period mentioned below : conditions of the a. For all items under Tab e -1: Maximum a.FO r all items under Tab e -1: Maximum tender of 30 days from the date of order in the of 30 days from the date of order in the Store Management Information System Store Management Information System (SMIS) from the procuring Unit(s). (SMIS) from the procurin g Unit(s). But additional 10 days may be allowed if order(s) is issued within 30 days from the date of issuance of approval notice of any item by DDHS (E&S), after satisfactory execution of keeping 10 % Buffer Stock for that item. ''Submission of 4. Annu al Turn Over of the Distributor, if Annu al Turn Over of the Distributor, if Tenders" in clause any, to be certified by CA firm which any, to be certified by CA firm which no. 9.I. (H) of the shou d not be less than 1 (two) crore for shou d not be less than 1 (One) crore for terms and the year 2015-16 or 2016-17 in Annexure the year 2015-16 or 2016-17 in Annexure conditions IV(b) lv(b) "Dates &Information" atclauseno.32.ofthetermsandconditionsofthetender I 5. Sn Items Publisingdate(s) Sn Items Publisingdate(s) 6. Bid Submission 06-07-2018 6. Bid Submission 13-07-2018 Closing Date(Online) upto 6.00 PM Closing Date(Online) upto 6.00 PM 7. Bid Opening Date 09-07-2018 7. Bid Opening Date 16-07-2018 (Online) - from 10.00 (Online) - from 10.00 Technical BID: AM Technical BID: AM 6. Change of Item Name : Uric Acid Test Kit Item Name : Uric Acid Test Kit Accounting Unit Cat. No. : U05/KCR Cat. No. : U05/KCR Accounting Unit: Per Test Accounting Unit: 1 ml 7. Change of Item Item Name : Glucostix Item Name : Glucostix [One Glucometer Name Cat. No. : Gll/KCR must be supplied free of Cost per 500 Accounting unit : Box of 100 Strips strips of Glucostix] Cat. No. : Gll/KCR Accounting Unit : Box of 100 Strips 8. Change of Item Item Name : BIVALENT ANTIGEN- Item Name : BIVALENT ANTIGEN- Name at SI. No. 42 DETECTING RAPID DIAG NOSTIC TESTS DETECTING RAPID DIAGNOSTIC TESTS (RDTS) FOR P. FALCIPARUM AND P. (RDTS) FOR P. FALCIPARUM AND P. VIVAX MALARIA UNDR NVBDCP....... of VIVAX MALARIA UNDR NVBDCP....... of incubation at room temperature, 350 C incubation at room temperature, 350 C and 450 C. conditi ons (room and 450 C. conditions (room temperature up to 400 C) . places temperature up to 400 C) . places (less than 300 C ) . .the sun. (less than 300 C ) . .the sun. 9. Change of Item HbsAg (Elisa) Kit HbsAg (Elisa) Kit Name at Sl. No.138 . .. cold chain during storage & . .. cold chain dtiring storage & transport the kits at 20 C - 80 C . transport the kits at 20 C - 80 C . dated 12th January 2015. dated 12th January 2015. 10. Change of Item HBSAg (Rapid) Kit HBSAg (Rapid) Kit Name at Sl. No.139 . .. cold chain during storage & . .. cold chain during storage & transport the kits at 20 C - 80 C . transport the kits at 20 C - 80 C . dated 12th January 2015. dated 12th January 2015 . 11. Change of Item HCV (Elisa) Kit HCV (Elisa) Kit Name at SI. No.140 . ... cold chain during storage & . ... cold chain during storage & transport the kits at 20 C - 80 C . transport the kits at 20 C - 8° C . dated 12th January 2015. dated 12th January 2015. 12. Change of Item HCV (Rapid) Kit HCV (Rapid) Kit Name at Sl. No.141 . .. cold chain during storage & . ... cold chain during storage & transport the kits at 20 C - 80 C . transport the kits at 20 C - 80 C . dated 12th January 2015. dated 12th January 2015. 13. Change of Item HIV (Elisa) Kit HIV (Elisa) Kit Name at Sl. No.145 . ... cold chain during storage & . ... cold chain during storage & transport the kits at 20 C - 80 C . transport the kits at 20 C - 80 C . dated 12th January 2015. dated 12th January 2015. 14. Change of Item HIV (Rapid) Testing Kits [By HIV (Rapid) Testing Kits [By Name at Sl. No.146 Principal ofEnzyme Immuno Assay, Principal of Enzyme lmmuno Assay, Agglutination, or any other Principle] Agglutination, or any other Principle] . .. cold chain during storage & . ... cold chain during storage & transport the kits at 20 C - 80 C . transport the kits at 2° C - 80 C . dated 12th January 2015. dated 12th January 2015. 15.I Change of Item TREPONEMAL-SPECIFIC RAPID TREPONEMAL-SPECIFIC RAPID Name at Sl. No. 237 (POINT-OF-CARE) DIAGNOSTIC (POINT-OF-CARE) DIAGNOSTIC TEST FOR SYPHILIS (POC Test Kit) TEST FOR SYPHILIS (POC Test Kit) . ... cold chain during storage & . ... cold chain during storage & transport the kits at 20 C - 80 C . transport the kits at 20 C - 80 C . dated 12th January 2015. dated 12th January 2015. Dy. Director of Health Services (E&S) West Bengal 3 Government of West Bengal Office of the Deputy Director of Health Services (E&S) Central Medical Stores 141, A J C Bose Road, Kolkata – 700 014 Phone No (033) 2265 4418/4417/4419 E mail : [email protected] NOTICE INVITING E TENDER FOR PROCUREMENT OF KITS, CHEMICALS & REAGENTS FOR TWO YEARS FROM THE DATE OF AWARD OF CONTRACT (AOC) (Through Pre-qualification) (Submission of Bid through NIC e tender portal) NIT No:-HST/4T-23-2018/CR/2018-20/058 Dated:13-06-2018 E-tender is hereby invited on behalf of the Health & Family Welfare Department, Government of West Bengal to prepare a Rate Schedule of supply of the listed items for a period of 2 (two) years from the date of Award of Contract(AOC)and its extension, if required, for a further period of 6 (Six) months, to the Central Medical Stores, District Reserve Stores, Medical Colleges & Hospitals, District and Sub District level Hospitals and other Direct Purchasing Health Units under the Health and Family Welfare Department, throughout the State of West Bengal. The Items as detailed in Table-1 of this Bid Document. Earnest money to be submitted for participation in the on-line Tender is Rs. 1,00,000/- (One lakh) only. Earnest money is payable in favour of the Deputy Director (Accounts), Central Medical Stores, Kolkata as on-line deposit through the Government Pooling account of the ICICI Bank.
Load more

Recommended publications
  • United States Patent 19 11 Patent Number: 5,648,064 Gaffar Et Al
    US005648064A United States Patent 19 11 Patent Number: 5,648,064 Gaffar et al. 45 Date of Patent: Jul. 15, 1997 (54) ORAL COMPOSITIONS HAVING 5,279,816 1/1994 Church et al. ............................ 424/53 ACCELERATED TOOTH WHTENING 5,302,374 4/1994 Wagner ..................................... 424/52 EFFECT 5,302,375 4/1994 Viscio ....................................... 424/53 5,356,554 10/1994 Delwel et al. ........................... 252/94 I76) Inventors: Abdul Gaffar, 89 Carter Rd., Princeton, 5,536,441 7/1996 Chapple et al. ................... 252A186.33 N.J. 08902; Sahar Fakhry-Smith. 7 FOREIGN PATENT DOCUMENTS Ryans Ct. Bordentown, N.J. 08505 0237111 9/1987 European Pat. Off. ......... C11D 3/39 (21) Appl. No.: 499,532 Primary Examiner-Shep K. Rose Attorney, Agent, or Firm-Paul Shapiro (22 Filed: Jul. 7, 1995 57 ABSTRACT (51] Int. Cl. .................. A61K 7/16; A61K7/20 52 U.S. Cl. ............................................... 424/53; 424/49 A two component whitening dentifrice composition is dis 58) Field of Search ................................... 424/53. 49-58 closed which comprises a first component containing a peroxygen compound such as hydrogen peroxide and a (56) References Cited second dentifrice component containing a manganese coor dination complex compound such as manganese gluconate, U.S. PATENT DOCUMENTS which activates the peroxygen compound and accelerates 4,728,455 3/1988 Rerek ........................................ 25299 the release of active oxygen for rapid whitening action, the 4,759,956 7/1988 Amer et al. ... 427/213 first and second components being maintained separate from 5,032,178 7/1991 Cornell ..................................... 106/35 the other until dispensed for application to teeth. 5, 194416 3/1993 Jureller et al.
    [Show full text]
  • Evaluating Disinfectants for Use Against the COVID-19 Virus
    When it comes to choosing a disinfectant to combat the COVID-19 virus, research and health authorities suggest not all disinfectants are equally effective. The difference is in their active ingredient(s). HEALTH CANADA AND U.S. EPA ASSESSMENTS The work to evaluate disinfectants perhaps best starts with lists of approved disinfectants compiled by government health authorities. Health Canada has compiled a list of 85 hard surface disinfectant products (as of March 20, 2020) that meet their requirements for disinfection of emerging pathogens, including the virus that causes COVID-19. It can be accessed here. You can wade through the entire list. But if you locate the Drug Identification Number (DIN) on the disinfectant product label or the safety data sheet (SDS), then you can use the search function to quickly see if the product meets Health Canada requirements. A second list, updated on March 19, 2020, provides 287 products that meet the U.S. Environmental Protection Agency’s (EPA) criteria for use against SARS-CoV-2, the novel coronavirus that causes the disease COVID-19. This list can be found here. Like the Health Canada list, you can wade through this one too. However, to best use this list, you should locate the U.S. EPA registration number on the product label or SDS, and use that number to search the list. The U.S. EPA registration number of a product consists of two sets of numbers separated by a hyphen. The first set of numbers refers to the company identification number, and the second set of numbers following the hyphen represents the product number.
    [Show full text]
  • FDA-2015-N-0101; and FDA-2016-N-0124
    DE PARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 November 18, 2020 Docket Nos. FDA-1975-N-0012; FDA-2015-N-0101; and FDA-2016-N-0124 The American Cleaning Institute Attention: James Kim, PhD Vice President, Science and Regulatory Affairs 1401 H Street, N.W. Suite 700 Washington, D.C. 20005 Re: Benzalkonium Chloride, Benzethonium Chloride, Chloroxylenol, Ethanol, and Povidone-Iodine Dear Dr. Kim: This letter responds to The American Cleaning Institute’s (ACI’s) July 14, 2020 communication regarding the deferral from final rulemaking under the over-the-counter (OTC) Drug Review on benzalkonium chloride, benzethonium chloride, chloroxylenol, ethanol, and povidone-iodine for use in nonprescription (often referred to as over-the-counter or OTC) consumer antiseptic wash, health care antiseptic, and consumer antiseptic rub drug products. In March 2016, FDA issued letters granting requests to defer three active ingredients— benzalkonium chloride, benzethonium chloride, and chloroxylenol—from inclusion in the final rulemaking for the December 2013 proposed rule for OTC consumer antiseptic washes (78 FR 76444). Similarly, in January 2017, FDA issued letters granting requests to defer six active ingredients—benzalkonium chloride, benzethonium chloride, chloroxylenol, ethanol, povidone- iodine, and isopropyl alcohol—from inclusion in the final rulemaking for the May 2015 proposed rule for OTC health care antiseptics (80 FR 25166). In October 2017, FDA issued letters granting requests to defer three active
    [Show full text]
  • Surface Morphology Alterations in Bovine Dentin Exposed to Different Bleaching Agents
    Braz J Oral Sci. Original Article January/March 2009 - Volume 8, Number 1 Surface morphology alterations in bovine dentin exposed to different bleaching agents Juliana Nascimento Santos1, Daniel Pinto de Oliveira1, Fábio Roberto Dametto1, Brenda Paula Figueiredo de Almeida Gomes2, Alexandre Augusto Zaia2, José Flávio Affonso de Almeida2, Caio Cezar Randi Ferraz2 1 DDS, MSc, PhD, Department of Restorative Dentistry and Endodontics, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas (Unicamp), Piracicaba (SP), Brazil 2 DDS, MSc, PhD, Professor, Department of Restorative Dentistry, Endodontics, Faculdade de Odontologia de Piracicaba, Unicamp, Piracicaba (SP), Brazil Abstract Aim: This study evaluated the morphological changes caused by internal bleaching agents on dentin surface. Methods: Twenty crowns of bovine incisors were cut into slabs that were randomly distributed in six experimental groups (n = 5), according to the bleaching agent used: G1 – sodium perborate + water, G2 – sodium perborate + 2% chlorhexidine gel, G3 – sodium perborate + 30% hydrogen peroxide, G4 – 30% hydrogen peroxide, G5 – 37% carbamide peroxide and G6 – gel base without carbamide. Two Control Groups were used: C1 with distilled water and C2 with 2% chlorhexidine gel. The specimens were immersed in the respective test bleaching agent and incubated at 37 °C for seven days. Following, they were prepared for scanning electron microscopy and five images from each tooth segment were recorded and analyzed for surface morphological alterations, by three previously calibrated examiners. Inter-examiner agreement was verified using the Kappa test. The rank averages obtained for the groups were subjected to Kruskal-Wallis analysis of variance at 5% significance level. Results: The analysis of the scores obtained indicated that all tested materials caused some morphological alteration on dentin, except for sodium perborate + water (G1) and Control Groups 1 and 2.
    [Show full text]
  • Which Disinfectants Work Best Against C. Difficile?
    Science at Your Doorstep WHICH DISINFECTANTS WORK BEST AGAINST C. DIFFICILE? Summary: In healthcare facilities, Clostridium difficile infections spread by transmission of bacterial spores. Appropriate sporicidal disinfectants are needed to prevent development of clusters and outbreaks. In this study, researchers in The Netherlands compared the effectiveness of 4 different disinfectant classes on killing distinctive C. difficile spores. They published their results in the respected journal, Antimicrobial Resistance & Infection Control. Hydrogen peroxide disinfectant wipes showed the highest bactericidal activity. Publication Description: According to the study, a dilution of sodium hypochlorite (chlorine bleach) has historically been used in hospitals to disinfect areas contaminated with C. difficile spores. But the authors state that “hypochlorite has to be used in excessive concentrations to be effective, thereby increasing its toxic and corrosive properties.” So the authors searched for alternative disinfectant types to eliminate C. difficile spores. The 4 different disinfectant compounds tested were: 1. Glucoprotamin 2. Hydrogen peroxide 3. Ethanol/propane/amino propyl glycine 4. Didecyldimonium chloride/benzalkonium chloride/biguanide (quat) Tiles were contaminated with a solution containing 5x106 CFU/ml spores of C. difficile. The tiles were left to dry for an hour and then wiped or sprayed with one of the sprays or wipes as intended by the manufacturers. After 5 minutes, microbiological cultures were performed. Conclusion: The authors concluded that for each active ingredient, the wipes performed better than the sprays. In general, impregnated cleaning/disinfection wipes performed better than ready-to-use sprays. Wipes with hydrogen peroxide showed the highest bactericidal activity. Reference: See article at: Antimicrobial Resistance & Infection Control; Volume 6, No.
    [Show full text]
  • Ammonium-Persulphate.Pdf
    ADVANCE An Exclusive Chemical Range CHEMICAL SALES CORPORATION CHEMICAL SUPPLIES SIMPLIFIED ABOUT US ADVANCE CHEMICAL SALES CORPORATION Advance Chemical Sales Corporation is an industrial distributor of Fine & Speciality Chemicals. It boasts of its technology-driven innovative ways in suppling products to its customers. ADVANCE CHEMICAL SALES CORPORATION (ACSC) has been a trusted supplier of chemicals since 1968. We like to work alongside customers and solve their challenges with efficiency, progressive solutions and quality products. Whether the order is for chemical commodities or speciality chemicals, no matter if the volume is large or small, we can handle it. We are committed to bring the best quality products at competitive prices from reputed manufacturers to our customers. Our goal is to make sure that our customers find their needs of chemicals in one place. We work to develop the customers' trust An Exclusive Chemical Range EXEMPLAR DELHI is in Trade and Import of ACIDS, INORGANIC CHEMICALS, METAL ORGANIC COMPOUNDS, ORGANIC CHEMICALS & SOLVENTS. EXEMPLAR NOIDA produces chemicals like ACETATES, CHELATED EDTA, CITRATES, EDTA SALTS, GLUCONATES, HEDP SALTS, OXALATES, PHOSPHATES, TARTRATES, FINE & PERFORMANCE CHEMICALS INDUSTRIES SERVED AGRO CHEMICALS DAIRY PAINTS & INKS CERAMIC & GLASS DETERGENTS PESTICIDES CHEMICAL INDUSTRIES FOOD PROCESSING PHARMACEUTICALS CONSTRUCTION LUBRICANTS POULTRY FEED COSMETICS METAL TREATMENT WATER TREATMENT CHEMICAL SUPPLIES SIMPLIFIED ACETATES AGRO CHEMICALS Ammonium acetate Amino acid (Protein hydrolysate) Calcium acetate Boron-20 Potassium acetate Disodium octaborate tetrahydrate Sodium acetate 3 hyd. Fulvic acid Sodium acetate anhy. Potassium humate Sodium diacetate Potassium humate fulvate Zinc acetate 2 hy. Seaweed extract ACIDS ALKALIES Acetic acid glacial Alumina trihydrate Adipic acid Aluminium oxide (Calcined) Ascorbic acid Ammonia solution Benzoic acid Ammonium carbonate Boric acid Calcium carbonate Citric acid mono/ anhy.
    [Show full text]
  • The Treatment of Acute Neerotizing Ulcerative Gingivitis Anne C
    Penodontics The treatment of acute neerotizing ulcerative gingivitis Anne C. Hartnett* / Jacob Shiloah** The destruction of tbe interdental papillae and formation of permanent gingiva! craierx are common sequelae of acute neerotizing uleerative gingivitis. These craters ean be disfiguring, especially in the anterior gingiva, and ean act as a nidus for recurrent epi- sodes. Traditional therapy has emphasized a stirgieal approach for elimination of Ihese defects, often increasing the esthelie problems. The pwpose of this paper is to review the treatment modalities of acitte neerotizing itlcerative gingivitis and ¡Ilústrate an al- ternative treatment approach of periodic sealing, root planing, and antimicrohiai rinses with 0.12% chlorhexidine. With this therapeutic regimen, the disease proeess ean be reversed and damaged papillae may regenérale. (Quintessence Int 1991:22:95-100.) Introduction chetes, fusifonn bacteria, and species of Bacteroides are the organisms most frequently cultivated from Acute neerotizing ulcerative gingivitis (ANUG) is a these lesions,' a definitive periodontal pathogen has rapidly destructive, noncommunicable, gingival infec- yet to be tmplicated in the onset or progression of tion of complex etiology. It is characterized by necrosis ANUG. A susceptible animal model in which to study of the crest of the gingival papillae, spontaneous ANUG has not been found. bleeding, pain, and halitosis. If left untreated, it may Previous studies have speculated on the importance spread laterally and apically to involve the entire
    [Show full text]
  • Entodinternational.Com ENTOD HOUSE, W-50(B), M.I.D.C, T.T.C
    Since 1977... Ocular Care & Wellness Since 1977 OUR OPHTHALMIC • Over 40 Years of Pharmaceutical & Nutraceutical Expertise RANGE AT A GLANCE • International Formulation R&D Centres • Technology-Driven Ophthalmics • WHO GMP & US FDA Accredited Manufacturing • Global Exports CONTACT US Head Office: Entod Pharmaceuticals Ltd., OPHTHALMIC FORMULATIONS R & D OPHTHALMIC SPECIALTY EXCIPIENTS Ashirwad Building, S.V. Road, Opp. Badi Masjid, Bandra(W), Mumbai-400050, INDIA Email: [email protected] Additional Office: 15 Tottenham Lane, London N8 9DJ, UK. E-mail: [email protected] A Global Research-Based Speciality Website: ophthalmicsuk.com Formulation R&D: Pharmaceutical Enterprise Medisearch Laboratory entodinternational.com ENTOD HOUSE, W-50(B), M.I.D.C, T.T.C. Indl. Estate, Rabale, Thane-Belapur Road, Follow us on: Navi Mumbai-400701, INDIA Email: [email protected] @entodinternational @entodpharma Entod Pharmaceuticals Medisearch Laboratories Entod Research 2018073 Ltd. (India) (Bombay) Pvt. Ltd. (India) Cell Ltd. (UK) entodinternational.com entodinternational.com Complete Ophthalmic Finished Products Range PRESS-DT TABLET OMEFLOX-BM EYE DROPS EYETAMIN CAPSULES MYOPIA CONTROL Acetazolamide IP 250mg Ofloxacin IP 0.3% w/w Lycopene, Lutein Zeaxanthin, Betamethasone Sodium Phosphate 0.1% w/w Vitamins & Minerals MYATRO EYE DROPS ENDOR EYE DROPS FLUCOCID EYE DROPS Fluconazole USP 0.3% w/v Atropine Sulphate USP 0.01% w/v Dorzolamide HCl USP 2% w/v TOBRACID-F EYE DROPS I-DEW MEGA CAPSULES Stabilized Oxychloro Complex 0.005% w/v Benzalkonium Chloride Solution IP 0.0075%w/v NATACIN EYE DROPS Tobramycin Sulphate USP Omega 3 fatty acid (deodourised) eqv. To ENDOR PLUS EYE DROPS Natamycin USP 5.0%w/v equi.
    [Show full text]
  • Food and Drugs
    21 Part 170 to 199 Revised as of April 1, 2001 Food and Drugs Containing a codification of documents of general applicability and future effect As of April 1, 2001 With Ancillaries Published by Office of the Federal Register National Archives and Records Administration A Special Edition of the Federal Register VerDate 11<MAY>2000 11:38 Apr 16, 2001 Jkt 194064 PO 00000 Frm 00001 Fmt 8091 Sfmt 8091 Y:\SGML\194064F.XXX pfrm02 PsN: 194064F U.S. GOVERNMENT PRINTING OFFICE WASHINGTON : 2001 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: (202) 512-1800 Tax: (202) 512-2250 Mail Stop: SSOP, Washington, DC 20402–0001 VerDate 11<MAY>2000 11:38 Apr 16, 2001 Jkt 194064 PO 00000 Frm 00002 Fmt 8092 Sfmt 8092 Y:\SGML\194064F.XXX pfrm02 PsN: 194064F Table of Contents Page Explanation ................................................................................................ v Title 21: Chapter I—Food and Drug Administration, Department of Health and Human Services (Continued) ................................................. 3 Finding Aids: Material Approved for Incorporation by Reference ............................ 573 Table of CFR Titles and Chapters ....................................................... 587 Alphabetical List of Agencies Appearing in the CFR ......................... 605 Redesignation Table ............................................................................ 615 List of CFR Sections Affected ............................................................. 617
    [Show full text]
  • Estonian Statistics on Medicines 2016 1/41
    Estonian Statistics on Medicines 2016 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 167,8985 A01 STOMATOLOGICAL PREPARATIONS 0,0738 A01A STOMATOLOGICAL PREPARATIONS 0,0738 A01AB Antiinfectives and antiseptics for local oral treatment 0,0738 A01AB09 Miconazole (O) 7088 g 0,2 g 0,0738 A01AB12 Hexetidine (O) 1951200 ml A01AB81 Neomycin+ Benzocaine (dental) 30200 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 680 g A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+ Thymol (dental) 3094 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 227150 g A01AD81 Lidocaine+ Cetrimide (O) 30900 g A01AD82 Choline salicylate (O) 864720 pieces A01AD83 Lidocaine+ Chamomille extract (O) 370080 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 405 g A02 DRUGS FOR ACID RELATED DISORDERS 47,1312 A02A ANTACIDS 1,0133 Combinations and complexes of aluminium, calcium and A02AD 1,0133 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 811120 pieces 10 pieces 0,1689 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3101974 ml 50 ml 0,1292 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3434232 pieces 10 pieces 0,7152 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 46,1179 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,3855 A02BA02 Ranitidine (O) 340327,5 g 0,3 g 2,3624 A02BA02 Ranitidine (P) 3318,25 g 0,3 g 0,0230 A02BC Proton pump inhibitors 43,7324 A02BC01 Omeprazole
    [Show full text]
  • Release of Antimicrobial Agents from Glass Ionomer Cements
    Y T E I C O S L BALKAN JOURNAL OF STOMATOLOGY A ISSN 1107 - 1141 IC G LO TO STOMA Release of Antimicrobial Agents from Glass Ionomer Cements SUMMARY Aleksandar Dimkov, Elizabeta Gjorgievska, The aim of this study was to determine the level of antimicrobial Aleksandar Fildishevski agents Benzalkonium Chloride and Cetylpyridinium Chloride released Faculty of Dentistry, Clinic for Pediatric and from ChemFlex, a conventional glass ionomer cement (GIC). The main null Preventive Dentistry, Skopje, FYROM hypothesis tested was that there is no release of antimicrobial agents into the surrounding medium. 3 groups of the conventional ChemFlex GIC of 5 samples each, with Benzalconium Chloride and CPC incorporated, were prepared - each group with a different percentage of the agents (1%, 2%, and 3%). The determination of the quantity of the antimicrobial agents was done by an UV- Spectrophotometer. The measurements were performed at 11 successive time intervals. The results of the statistical analysis point out that it is possible to incorporate these antimicrobial agents in conventional GIC, especially when the added percentage of the antimicrobial agents is 3%. ORIGINAL PAPERS (OP) Keywords: GIC; Antimicrobial Agents; UV-Spectrophotometry Balk J Stom, 2012; 16:84-89 Introduction application9. There are several studies dealing with the effect of incorporating chlorhexidine in different Because of the relatively frequent occurrence of concentrations and its combinations in GIC to improve recurrent caries after a restorative treatment, and because their antimicrobial properties10-14. of the huge number of cariogenic microorganisms There are only a few data in the literature referring existing in the oral cavity, which present a potential to the incorporation and release of other antimicrobial risk factor regarding the development of new carious components in GIC.
    [Show full text]
  • Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services
    Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services Australian Statistics on Medicines 1997 i © Commonwealth of Australia 1998 ISBN 0 642 36772 8 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be repoduced by any process without written permission from AusInfo. Requests and enquiries concerning reproduction and rights should be directed to the Manager, Legislative Services, AusInfo, GPO Box 1920, Canberra, ACT 2601. Publication approval number 2446 ii FOREWORD The Australian Statistics on Medicines (ASM) is an annual publication produced by the Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee. Comprehensive drug utilisation data are required for a number of purposes including pharmacosurveillance and the targeting and evaluation of quality use of medicines initiatives. It is also needed by regulatory and financing authorities and by the Pharmaceutical Industry. A major aim of the ASM has been to put comprehensive and valid statistics on the Australian use of medicines in the public domain to allow access by all interested parties. Publication of the Australian data facilitates international comparisons of drug utilisation profiles, and encourages international collaboration on drug utilisation research particularly in relation to enhancing the quality use of medicines and health outcomes. The data available in the ASM represent estimates of the aggregate community use (non public hospital) of prescription medicines in Australia. In 1997 the estimated number of prescriptions dispensed through community pharmacies was 179 million prescriptions, a level of increase over 1996 of only 0.4% which was less than the increase in population (1.2%).
    [Show full text]